It has found that miR-130a-3p could target Smad4 and that overexpression of miR-130a-3p or downregulation of Smad4 could inhibit cell detachment, adhesion, migration, and invasion of gemcitabine-resistant HCC (GR-HCC) cells (70). This evidence concerns the gene SMAD4 and hepatocellular carcinoma.